ASX - By Stock
|
EMV |
Re:
Random AGM notes & quotes
|
|
musky45
|
27 |
8.2K |
9 |
16/11/22 |
16/11/22 |
ASX - By Stock
|
27
|
8.2K
|
9
|
|
ASX - By Stock
|
IPD |
Re:
Ann: PREVENT Trial Peer-Reviewed and Published
|
|
musky45
|
21 |
9.6K |
14 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
21
|
9.6K
|
14
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Notification of cessation of securities - AVR
|
|
musky45
|
8 |
3.4K |
8 |
12/01/22 |
12/01/22 |
ASX - By Stock
|
8
|
3.4K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
AVRO
|
|
musky45
|
422 |
105K |
18 |
02/01/22 |
02/01/22 |
ASX - By Stock
|
422
|
105K
|
18
|
|
Charts
|
IPD |
Re:
IPD chart
|
|
musky45
|
816 |
341K |
2 |
07/12/21 |
07/12/21 |
Charts
|
816
|
341K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Change of Director's Interest Notice
|
|
musky45
|
13 |
3.6K |
3 |
07/12/21 |
07/12/21 |
ASX - By Stock
|
13
|
3.6K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Change in substantial holding
|
|
musky45
|
7 |
2.0K |
6 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
7
|
2.0K
|
6
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Change in substantial holding
|
|
musky45
|
8 |
2.9K |
3 |
21/10/21 |
21/10/21 |
ASX - By Stock
|
8
|
2.9K
|
3
|
|
ASX - By Stock
|
IPD |
Re:
General
|
|
musky45
|
975 |
716K |
11 |
28/09/21 |
28/09/21 |
ASX - By Stock
|
975
|
716K
|
11
|
|
ASX - By Stock
|
ICQ |
Re:
Ann: Trading halt
|
|
musky45
|
20 |
5.3K |
0 |
12/07/21 |
12/07/21 |
ASX - By Stock
|
20
|
5.3K
|
0
|
|
ASX - By Stock
|
ICQ |
Re:
Ann: Trading halt
|
|
musky45
|
20 |
5.3K |
0 |
12/07/21 |
12/07/21 |
ASX - By Stock
|
20
|
5.3K
|
0
|
|
ASX - By Stock
|
SPX |
Re:
Ann: Binding Share Sale Agreement to Acquire Invigo
|
|
musky45
|
200 |
69K |
16 |
05/07/21 |
05/07/21 |
ASX - By Stock
|
200
|
69K
|
16
|
|
ASX - By Stock
|
AVR |
Re:
Price Predictions - End of Year
|
|
musky45
|
90 |
28K |
6 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
90
|
28K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
ComASUR™ TF Del System
|
|
musky45
|
20 |
7.1K |
30 |
18/04/21 |
18/04/21 |
ASX - By Stock
|
20
|
7.1K
|
30
|
|
ASX - By Stock
|
AVR |
Re:
FNN Presentation .. WOW!
|
|
musky45
|
160 |
50K |
7 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
160
|
50K
|
7
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Appendix 4C - Quarter ended 31 December 2020
|
|
musky45
|
20 |
7.3K |
7 |
28/01/21 |
28/01/21 |
ASX - By Stock
|
20
|
7.3K
|
7
|
|
ASX - By Stock
|
IBX |
Re:
Breakthrough Device Regulatory win
|
|
musky45
|
16 |
6.6K |
2 |
17/01/21 |
17/01/21 |
ASX - By Stock
|
16
|
6.6K
|
2
|
|
ASX - By Stock
|
IBX |
Re:
Breakthrough Device Regulatory win
|
|
musky45
|
16 |
6.6K |
7 |
16/01/21 |
16/01/21 |
ASX - By Stock
|
16
|
6.6K
|
7
|
|
ASX - By Stock
|
IBX |
Breakthrough Device Regulatory win
|
|
musky45
|
16 |
6.6K |
33 |
16/01/21 |
16/01/21 |
ASX - By Stock
|
16
|
6.6K
|
33
|
|
ASX - By Stock
|
AVR |
Re:
Interview on the Market Herald with Wayne.
|
|
musky45
|
78 |
25K |
2 |
15/01/21 |
15/01/21 |
ASX - By Stock
|
78
|
25K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Funding Package
|
|
musky45
|
91 |
25K |
8 |
14/01/21 |
14/01/21 |
ASX - By Stock
|
91
|
25K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Placement
|
|
musky45
|
48 |
11K |
3 |
31/12/20 |
31/12/20 |
ASX - By Stock
|
48
|
11K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Placement
|
|
musky45
|
48 |
11K |
4 |
31/12/20 |
31/12/20 |
ASX - By Stock
|
48
|
11K
|
4
|
|
ASX - By Stock
|
WGB |
Re:
Ann: WAM Global FY2021 interim dividend guidance, 66.7% increase
|
|
musky45
|
9 |
3.8K |
3 |
11/12/20 |
11/12/20 |
ASX - By Stock
|
9
|
3.8K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Anti-calcification Comparison Study Interim Results
|
|
musky45
|
96 |
22K |
7 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
96
|
22K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: DurAVR SELECTED AS A BEST INNOVATION - PCR LONDON VALVES
|
|
musky45
|
19 |
5.0K |
11 |
25/11/20 |
25/11/20 |
ASX - By Stock
|
19
|
5.0K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
Ann: DurAVR SELECTED AS A BEST INNOVATION - PCR LONDON VALVES
|
|
musky45
|
19 |
5.0K |
16 |
23/11/20 |
23/11/20 |
ASX - By Stock
|
19
|
5.0K
|
16
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence Strategic Repositioning, Change in CEO
|
|
musky45
|
100 |
29K |
0 |
21/11/20 |
21/11/20 |
ASX - By Stock
|
100
|
29K
|
0
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence Strategic Repositioning, Change in CEO
|
|
musky45
|
100 |
29K |
2 |
21/11/20 |
21/11/20 |
ASX - By Stock
|
100
|
29K
|
2
|
|
ASX - By Stock
|
MSL |
Re:
Ann: Becoming a substantial holder
|
|
musky45
|
1 |
863 |
2 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
1
|
863
|
2
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence Strategic Repositioning, Change in CEO
|
|
musky45
|
100 |
29K |
5 |
17/11/20 |
17/11/20 |
ASX - By Stock
|
100
|
29K
|
5
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence Strategic Repositioning, Change in CEO
|
|
musky45
|
100 |
29K |
6 |
17/11/20 |
17/11/20 |
ASX - By Stock
|
100
|
29K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Anti-calcification Comparison Study Interim Results
|
|
musky45
|
96 |
22K |
13 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
96
|
22K
|
13
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Anti-calcification Comparison Study Interim Results
|
|
musky45
|
96 |
22K |
9 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
96
|
22K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Anti-calcification Comparison Study Interim Results
|
|
musky45
|
96 |
22K |
9 |
14/11/20 |
14/11/20 |
ASX - By Stock
|
96
|
22K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Anti-calcification Comparison Study Interim Results
|
|
musky45
|
96 |
22K |
11 |
13/11/20 |
13/11/20 |
ASX - By Stock
|
96
|
22K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Anti-calcification Comparison Study Interim Results
|
|
musky45
|
96 |
22K |
11 |
13/11/20 |
13/11/20 |
ASX - By Stock
|
96
|
22K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Anti-calcification Comparison Study Interim Results
|
|
musky45
|
96 |
22K |
5 |
12/11/20 |
12/11/20 |
ASX - By Stock
|
96
|
22K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Anti-calcification Comparison Study Interim Results
|
|
musky45
|
96 |
22K |
11 |
10/11/20 |
10/11/20 |
ASX - By Stock
|
96
|
22K
|
11
|
|
ASX - By Stock
|
EYE |
Re:
Ann: Establishment of AlpaRET
|
|
musky45
|
4 |
1.7K |
0 |
26/10/20 |
26/10/20 |
ASX - By Stock
|
4
|
1.7K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 4D and Half Yearly Financial Report
|
|
musky45
|
10 |
2.8K |
3 |
21/08/20 |
21/08/20 |
ASX - By Stock
|
10
|
2.8K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
SAVR trial results to be presented at major conference.
|
|
musky45
|
29 |
9.7K |
8 |
20/08/20 |
20/08/20 |
ASX - By Stock
|
29
|
9.7K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
DurAVR presented at TAVR innovation awards.
|
|
musky45
|
11 |
3.8K |
22 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
11
|
3.8K
|
22
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence Achieves Positive Quarterly Cashflow
|
|
musky45
|
28 |
8.9K |
1 |
12/07/20 |
12/07/20 |
ASX - By Stock
|
28
|
8.9K
|
1
|
|
ASX - By Stock
|
FLC |
Re:
Ann: Fluence Achieves Positive Quarterly Cashflow
|
|
musky45
|
28 |
8.9K |
12 |
10/07/20 |
10/07/20 |
ASX - By Stock
|
28
|
8.9K
|
12
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Early TAVR Animal Study commenced
|
|
musky45
|
10 |
3.3K |
5 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
10
|
3.3K
|
5
|
|
ASX - By Stock
|
EYE |
Re:
When will they call a trading halt?
|
|
musky45
|
13 |
3.8K |
1 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
13
|
3.8K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Early TAVR Animal Study commenced
|
|
musky45
|
10 |
3.3K |
14 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
10
|
3.3K
|
14
|
|
ASX - By Stock
|
EYE |
Re:
Ann: ACCC clears Ellex Lumibird transaction
|
|
musky45
|
3 |
1.6K |
0 |
13/06/20 |
13/06/20 |
ASX - By Stock
|
3
|
1.6K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
CEO Interview - Wayne Paterson
|
|
musky45
|
13 |
5.1K |
10 |
07/06/20 |
07/06/20 |
ASX - By Stock
|
13
|
5.1K
|
10
|
|